GlobeStar Therapeutics Corporation
GSTC
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 53.48% | -152.00% | -47.41% | -31.01% | 64.96% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -25.36% | -13.26% | -39.21% | -39.12% | -70.76% |
| Total Other Non-Cash Items | -87.69% | 1,615.32% | 138.35% | 90.90% | -73.14% |
| Change in Net Operating Assets | 6.95% | 0.77% | -12.94% | 0.52% | 99.96% |
| Cash from Operations | 13.58% | 6.30% | 11.46% | 37.08% | 75.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 302.11% | 196.96% | 186.39% | 105.54% | -0.84% |
| Total Debt Repaid | -154.55% | 12.12% | 66.67% | 66.67% | 66.67% |
| Issuance of Common Stock | 47.25% | 425.00% | 750.00% | 1,350.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | -81.00% | -76.45% | -84.15% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.63% | -6.25% | -9.51% | -39.10% | -75.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.00% | 33.33% | 43.38% | -1,360.00% | 100.49% |